Demonstrating non-inferiority of bio-fluorescent particle counter (BFPC) technology to traditional active air-sampling methods is essential for implementation. Here's how to approach it.
- The Missing Layer: Why CAR-T Needs AI As Its Connective Tissue
- Building A Self-Driving Lab For LNP Development
- Unlocking Gentler, Cost-Efficient TIL Therapy For Cold Tumors
- Full FDA Approval For TECELRA Marks More Than A Regulatory Win For Solid Tumors
- Addressing The Particulate Challenge In Cell Therapy Products
- Let's Stop Treating Allogeneic Cell Therapy As One Thing
- Allogeneic Cell Therapy Is Still Learning What Biology Will Allow
- Reassessing Nanoparticle Immunotoxicity: From Well-Established To Novel Approaches
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1751659695-laboratory-scientists-computer-analysis-evaluation]( "CQA Assessment Of LNP-Encapsulated IVT mRNA")
CQA Assessment Of LNP-Encapsulated IVT mRNALearn more about issued guidelines on Critical Quality Attributes for IVT mRNA vaccines and biotherapeutics to focus on drug substance and LNP-encapsulated drug product assessment using an analyzer system.
-
![GettyImages-1470034194-magnifying-glass-charts-calculator]( "Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators")
Economic Advantage Of Robotic Gloveless Pharmaceutical IsolatorsAre robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
![SUS - products]( "Single-Use Assembly Capabilities To Keep Pace With Biopharma Dynamics")
Single-Use Assembly Capabilities To Keep Pace With Biopharma DynamicsDiscover how a vendor-independent partner assists global life science companies and CDMOs with innovative single-use technologies to mitigate risks and ensure uninterrupted manufacturing.
-
![GettyImages-1412800224-scientist-examining-filter-in-lab]( "A Sterilizing-Grade Membrane For Efficient Filtration Of Biologics")
A Sterilizing-Grade Membrane For Efficient Filtration Of BiologicsHigher flow rates and a smaller process footprint can create meaningful gains across sterile filtration steps. Explore the performance data and where efficiency improvements may be possible.
-
![Thermo Fisher - SUB]( "Scalability From 5L To 50L Using The DynaDrive Single-Use Bioreactor")
Scalability From 5L To 50L Using The DynaDrive Single-Use BioreactorMaintaining a consistent bioprocess when scaling from 5 L to 50 L is achievable. This study shows how to successfully scale processes while maintaining cell density, viability, and protein production.
-
![SpectraMax iD5e multi-mode microplate reader plate tray open microplate showcased improve cell viability]( "Improved Cell Viability For Multi-Day Cell-Based Assays")
Improved Cell Viability For Multi-Day Cell-Based AssaysEnsure consistent cell health and assay reliability with controlled temperature and gas conditions. Discover how microplate readers with gas mixers enhance cell viability in live cell-based assays.
-
![GettyImages-1185624320-scientist-lab-smiling]( "Leveraging Integrated Media Services For Speed And Efficiency")
Leveraging Integrated Media Services For Speed And EfficiencyUncertainty in media stability can limit efficiency and scalability in biologics manufacturing. See how a data-driven approach enables more predictable planning and reduces operational strain.
-
![GettyImages-1165637777 DNA]( "Analysis Of DNA Integrity And Stability Using Digital PCR")
Analysis Of DNA Integrity And Stability Using Digital PCRDigital PCR offers precise, inhibitor-resistant DNA quantification and genome integrity assessment. Discover how this method enhances accuracy and reproducibility, especially in AAV analysis, using multiplexed targets and Poisson-based calculations.
-
![GettyImages-2192786673 antibodies]( "Integrated Upstream And Downstream Strategies For Robust Manufacturing")
Integrated Upstream And Downstream Strategies For Robust ManufacturingProcess robust mAb production requires understanding scale dependent cell environments, leveraging predictive models, and pursuing data driven control to minimize variability and optimize quality.
-
![Supply Chain Management GettyImages-1304746031]( "The Unique Challenges Of The Cell & Gene Therapy Supply Chain")
The Unique Challenges Of The Cell & Gene Therapy Supply ChainCell and gene therapies present unique logistical challenges for the supply chain, requiring careful consideration of factors like shelf life, packaging, temperature, and chain of custody.
NEWSLETTER ARCHIVE
- 07.24.26 -- Unlocking Gentler, Cost-Efficient TIL Therapy For Cold Tumors
- 07.23.26 -- CGT Biotech/CDMO Transparency & Core Capabilities
- 07.22.26 -- Accelerate Your Gene Therapy Pipeline with NGS, AAV Clearance, and Virus Bank Expertise
- 07.22.26 -- Wondering If Your Org Should Purchase R&D Datasets?
- 07.21.26 -- STREAM Edition: How To Match CGT Manufacturing Models To Pipeline Needs
- Solving Vector Yield Challenges Starts Long Before Manufacturing
- Full FDA Approval For TECELRA Marks More Than A Regulatory Win For Solid Tumors
- FDA Approval Of TREGZI Signals A New Era For Precision Engineered Cell Therapy
- How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale
- In Vivo Gene Editing Is Moving From Promise To Proof
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
